At a glance
The FY26 Melanoma Research Program Survivorship Research Award funds innovative research to improve the health and well-being of melanoma survivors, their families, and care partners. Clinical trials are allowed, but studies focused only on animal models or on survival without quality of life, health, or function are not responsive. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit, public or private organizations; the principal investigator must be an independent investigator at or above assistant professor level or equivalent. The program expects to fund about two awards at roughly $1.02 million total cost cap each, with no cost-sharing requirement and a maximum project period of 3 years. Applications must include at least one melanoma consumer collaborator, and the program says research involving military or Veteran populations, data, or resources is highly encouraged.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed.
Who can apply
- Unrestricted